Company
Columbia Care, Inc.
Headquarters: New York, NY, United States
CEO: Mr. Nicholas Keane Vita
Market Cap
$192.6 Million
USD as of July 1, 2023
Columbia Care, Inc. Categories
United States Healthcare Drug Manufacturers—Specialty & GenericUnited States Healthcare United States Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Columbia Care Inc. cultivates, manufactures, and provides cannabis-based health and wellness solutions, and derivative products. It offers flowers, edibles, oils, and tablets under the Cannabist, Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label Cannabidiol brands. The company holds licenses in 18 jurisdictions in the United States and the European Union. As of January 3, 2022, it operated 131 facilities, including 99 dispensaries and 32 cultivation and manufacturing facilities. The company was founded in 2012 and is headquartered in New York, New York.
Stocks & Indices
Columbia Care, Inc. has the following listings and related stock indices.
Stock: OTC: CCHWF wb_incandescent
Stock: CSE: CCHW wb_incandescent
Stock: FSX: 3LP wb_incandescent